Framework agreement for medicines under the National Oncology Programme and Cost-Volume Agreement (PNO4)

Summary

Odorheiu Secuiesc Municipal Hospital is procuring medicines in 11 lots for the national oncology programme and other healthcare programmes. The medicines include carfilzomib, decitabine, sacituzumab govitecan, pembrolizumab, trastuzumab deruxtecan, isatuximab, tafasitamab, BCG vaccine, fluorouracil and tenecteplase. A 24-month framework agreement will be concluded, with orders placed annually, every six months or monthly according to need and available funding. The framework agreement has an estimated maximum value of RON 22,466,042.26. Bids must be submitted electronically by 15:00 on 12 November 2026. Price is the sole award criterion; the lowest total-priced bid is selected for each lot. Bidders must hold a wholesale medicines distribution authorisation and an ISO 9001 or equivalent quality-management system, and must provide evidence of legal registration and the required declarations. No bid guarantee is required.